Article
Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake
2024-09-04
Abstract excerpt
<title>Abstract</title> <p>The gut microbiome has been shown to be affected by the use of many human-targeted medications, and the interaction can be bidirectional. This has been clearly demonstrated for type 2 diabetes medications that have been in clinical use for several decades. However, the bidirectional effects of novel type 2 diabetes drugs semaglutide, empagliflozin, and the gut microbiome have yet to be...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a4fa682-dbbe-5a8e-8fe2-9f14a700f9a9
- DOI
- 10.21203/rs.3.rs-4823981/v1
